Kerecis Ltd.

Coloplast plans to acquire Iceland-based biotech company Kerecis for up to $1.3bn to improve its biologics offerings in the rapidly growing advanced would care market, especially in the US. The com

Company Changes BANTOCK , Pete BARBER , Alan BUHLER , John T. DOREE , Gavin ERIKSEN , Peter Mørch FRANCISCHELLI , David To: AtriCure Inc. , VP, R&D, Structural Heart (August) From: Medtro

by Susan Paquette and Sharon O'Reilly With estimated revenues in excess of $5 billion per year worldwide, the advanced wound care market has garnered the attention of both major companies and investor

In Vitro Diagnostics KellBenx Inc. Seed funding brings in $2.4mm for KellBenx KellBenx Inc. (noninvasive prenatal diagnostics for genetic disorders) has raised $2.4mm through its seed round. Of th